Eastern Bank’s Akero Therapeutics AKRO Stock Holding History

Eastern Bank’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,500	Closed	-$166K	–	1168
2025 Q3	$166K	Hold	3,500	–	–	﹤0.01%	383
2025 Q2	$187K	Hold	3,500	–	–	﹤0.01%	361
2025 Q1	$142K	Hold	3,500	–	–	﹤0.01%	401
2024 Q4	$97.4K	Hold	3,500	–	–	﹤0.01%	475
2024 Q3	$100K	Buy	+3,500	New	+$91.3K	﹤0.01%	462

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Eastern Bank's AKRO Position: Q4 2025 in Review

Eastern Bank sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 3,500 shares — an estimated $166K sold.

Eastern Bank first reported a position in AKRO in Q3 2024 and held it in 5 quarters. The position peaked at $187K in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Eastern Bank reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Eastern Bank sold 3,500 Akero Therapeutics shares in Q4 2025, an estimated $166K.
Eastern Bank first reported a position in Akero Therapeutics in Q3 2024 and held it in 5 quarters.
Eastern Bank's Akero Therapeutics position peaked at $187K in Q2 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Eastern Bank's 13F filing for Q4 2025, filed 14 Jan 2026.